Table of Contents Author Guidelines Submit a Manuscript
Journal of Analytical Methods in Chemistry
Volume 2015, Article ID 974039, 9 pages
http://dx.doi.org/10.1155/2015/974039
Research Article

Simultaneous Determination of Six Active Compounds in Yixin Badiranjibuya Granules, a Traditional Chinese Medicine, by RP-HPLC-UV Method

1College of Pharmacy, Shihezi University, Shihezi 832002, China
2Xinjiang Institute of Metaria Medica, Urumqi 830004, China
3Institute of Traditional Chinese Medicine, Xinjiang Medical University, Urumqi 830005, China
4Department of Pharmaceutics, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100052, China

Received 26 May 2015; Revised 2 August 2015; Accepted 3 August 2015

Academic Editor: Vito Verardo

Copyright © 2015 Ning Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. The Chinese Pharmacopoeia Commission, The Fascicle of Uygur Medicine of Drug Standard of Ministry of Public Health of the Peoples Republic of China, Xinjiang Science and Technology Health Press, Ürümqi, China, 1999.
  2. G. Mmtiyiming and M. Ayinuer, “The clinical curative analysis of Uygur medicine Yixinbadiranjibuya granules treat cardiovascular disease,” Chinese Journal of Ethnomedicine and Ethnopharmacy, no. 2, pp. 11–12, 2014. View at Google Scholar
  3. C. Ibarra-Alvarado, A. Rojas, S. Mendoza et al., “Vasoactive and antioxidant activities of plants used in Mexican traditional medicine for the treatment of cardiovascular diseases,” Pharmaceutical Biology, vol. 48, no. 7, pp. 732–739, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Martínez-Vázquez, R. Estrada-Reyes, A. Martínez-Laurrabaquio, C. López-Rubalcava, and G. Heinze, “Neuropharmacological study of Dracocephalum moldavica L. (Lamiaceae) in mice: sedative effect and chemical analysis of an aqueous extract,” Journal of Ethnopharmacology, vol. 141, no. 3, pp. 908–917, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Maimaitiyiming, G. Hu, A. Aikemu, S. W. Hui, and X. Zhang, “The treatment of Uygur medicine Dracocephalum moldavica L on chronic mountain sickness rat model,” Pharmacognosy Magazine, vol. 10, no. 40, pp. 477–482, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Tian, J. Shang, T. He, M. Cai, and D. Abdelkader, “Study on material basis of Dracocephalum moldavica for protecting cardiomyocyte against hypoxia/reoxygenation injury by traditional Chinese medicine serum chemical and pharmacological methods,” Chinese Journal of Chinese Materia Medica, vol. 37, no. 5, pp. 620–624, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. C.-M. Guo, R.-L. Wu, S. Feng, and J.-D. Wang, “Dracocephalum moldavica L. polysaccharide extraction, determination and the active oxygen free radical scavenging effect,” Food and Fermentation Industries, vol. 31, no. 3, pp. 129–132, 2005. View at Google Scholar
  8. K. Dastmalchi, H. J. Damien Dorman, I. Laakso, and R. Hiltunen, “Chemical composition and antioxidative activity of Moldavian balm (Dracocephalum moldavica L.) extracts,” LWT—Food Science and Technology, vol. 40, no. 9, pp. 1655–1663, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Xing, K. Peng, W. Cao, X. Lian, Q. Wang, and X. Wang, “Effects of total flavonoids from Dracocephalum moldavica on the proliferation, migration, and adhesion molecule expression of rat vascular smooth muscle cells induced by TNF-α,” Pharmaceutical Biology, vol. 51, no. 1, pp. 74–83, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. C.-G. Feng and Q. Li, “Review of chemical constituents of Dracocephalum moldavica L. and their pharmacological activities,” Chinese Traditional Patent Medicine, vol. 25, no. 2, pp. 154–156, 2003. View at Google Scholar
  11. L.-N. Yang, J.-G. Xing, C.-H. He, and T. Wu, “Chemical constituents of Dracocephalum moldavica L. and their pharmacological activities,” World Clinical Drugs, vol. 34, no. 4, pp. 226–231, 2014. View at Google Scholar
  12. L.-N. Yang, J.-G. Xing, C.-H. He, and T. Wu, “The phenolic compounds from Dracocephalum moldavica L.,” Biochemical Systematics and Ecology, vol. 54, pp. 19–22, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Guo, W. Cao, J. Yao et al., “Cardioprotective effects of tilianin in rat myocardial ischemia-reperfusion injury,” Molecular Medicine Reports, vol. 11, no. 3, pp. 2227–2233, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. S.-M. Ma, R. Liu, X.-L. Ren, A.-D. Qi, and Y.-B. Li, “Determination of luteolin-7-O-β-D-glucopyranoside, luteolin-7-O-β-D-glucuronopyranoside, and apigenin-7-O-β-D-glucuronopyranoside in Ixeris sonchifolia by HPLC-DAD,” Modern Drugs and Clinic, vol. 29, no. 4, pp. 377–380, 2014. View at Google Scholar
  15. J.-G. Xing, W.-J. Cao, X.-C. Wang, J.-G. Jin, and K.-J. Peng, “Inhibitory effects of tilianin on proliferation and migration of rat vascular smooth muscle cells induced by TNF-α,” Chinese Materia Medica and Clinical Pharmacology, vol. 27, no. 4, pp. 17–20, 2011. View at Google Scholar
  16. W.-J. Cao, K.-J. Peng, and Y. Yuan, “Effects of tilianin on the level of serum lipids and inflammatory factors in rats,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 19, no. 11, pp. 164–167, 2013. View at Google Scholar
  17. V. Povilaityte, P. R. Venskutonis, and M. E. Cuvelier, “Antioxidant constituents in moldavian dragonhead (Dracocephalum moldavica L) extracts,” in Food Technology and Quality Evaluation, vol. 2003, pp. 195–202, CRC Press, 2001. View at Google Scholar
  18. Y.-J. Zhang, W.-Q. Xu, and X. Shen, “New progress in the research of rosmarinic acid separation, purification and pharmacological actions,” Chinese Journal of New Drugs, vol. 22, no. 4, pp. 433–437, 2013. View at Google Scholar · View at Scopus
  19. J.-Z. Wu, J.-P. Yu, and D.-L. Zhao, “Progress in the research on rosmarinic acid,” Natural Product Research and Development, vol. 17, no. 3, pp. 283–288, 2005. View at Google Scholar
  20. M. B. Hossain, G. Camphuis, I. Aguiló-Aguayo, N. Gangopadhyay, and D. K. Rai, “Antioxidant activity guided separation of major polyphenols of marjoram (Origanum majorana L.) using flash chromatography and their identification by liquid chromatography coupled with electrospray ionization tandem mass spectrometry,” Journal of Separation Science, vol. 37, no. 22, pp. 3205–3213, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. ICH Expert Working Group, “ICH, Q2(R1), harmonized tripartite guideline, validation of analytical procedures: text and methodology,” in Proceedings of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1994.
  22. Y.-F. Wang, J.-G. Xing, C.-H. He, and G.-P. Xue, “Study on quality standard of Yixin Badiranjibuya Granules,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 18, no. 1, pp. 87–89, 2012. View at Google Scholar
  23. Y.-L. Li, J. Li, N.-L. Wang, and X.-S. Yao, “Flavonoids and a new polyacetylene from Bidens parviflora Willd,” Molecules, vol. 13, no. 8, pp. 1931–1941, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Murata, T. Miyase, and F. Yoshizaki, “Cyclic spermidine alkaloids and flavone glycosides from Meehania fargesii,” Chemical and Pharmaceutical Bulletin, vol. 58, no. 5, pp. 696–702, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. L. Jun, J. C. Eun, J. K. Hyo, H. P. Jun, and W. C. Sang, “Antioxidative flavonoids from leaves of Carthamus tinctorius,” Archives of Pharmacal Research, vol. 25, no. 3, pp. 313–319, 2002. View at Publisher · View at Google Scholar · View at Scopus